PharmaCyte Biotech (PMCB) Non-Current Assets (2011 - 2026)
PharmaCyte Biotech (PMCB) reported Non-Current Assets of $5.74 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), down 77.9% from $26 million a year earlier and down 38.5% from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Non-Current Assets (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Apr 30, 2026), PharmaCyte Biotech posted Non-Current Assets of $9.33 million, down 71.5% from FY2025.
- Non-Current Assets has a five-year compound annual growth rate of 12.7% (FY2021 to FY2026).
- By fiscal year, Non-Current Assets came in at $32.79 million in FY2025 (+246.5%), $9.46 million in FY2024 (+84.5%), $5.13 million in FY2023 (unchanged) and $5.13 million in FY2022 (unchanged).
- The fiscal Q1 2027 figure ranks as the lowest quarterly Non-Current Assets since fiscal Q2 2024.
- Year over year, Non-Current Assets gained in four of the last eight quarters, with growth averaging 103.3%.
- The high point for year-over-year Non-Current Assets in five years was fiscal Q1 2025 (growth of 627.6%); the low point was fiscal Q1 2027 (a decline of 77.9%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $9.33 million (Q4 2026), $35.18 million (Q3 2026) and $32.95 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 14.88 Bn |
| 10 | PharmaCyte Biotech | 4.40 Mn | 4.40 Mn | - | 5.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 5.74 Mn |
| Apr 30, 2026 | 9.33 Mn |
| Jan 31, 2026 | 35.18 Mn |
| Oct 31, 2025 | 32.95 Mn |
| Jul 31, 2025 | 26.00 Mn |
| Apr 30, 2025 | 32.79 Mn |
| Jan 31, 2025 | 26.87 Mn |
| Oct 31, 2024 | 33.77 Mn |
| Jul 31, 2024 | 37.32 Mn |
| Apr 30, 2024 | 9.46 Mn |
| Jan 31, 2024 | 9.85 Mn |
| Oct 31, 2023 | 5.13 Mn |
| Jul 31, 2023 | 5.13 Mn |
| Apr 30, 2023 | 5.13 Mn |
| Jan 31, 2023 | 5.13 Mn |
| Oct 31, 2022 | 5.13 Mn |
| Jul 31, 2022 | 5.13 Mn |
| Apr 30, 2022 | 5.13 Mn |
| Jan 31, 2022 | 5.13 Mn |
| Oct 31, 2021 | 5.13 Mn |
API Access
PharmaCyte Biotech Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();